Cytori Cell Research Institute, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-2,152.00
-1,011.00
-1,166.00
-65.00
-654.00
319.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-267.00
116.00
713.00
-45.00
139.00
98.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-987.00
-1,152.00
-39.00
-187.00
-82.00
531.00
Cash Flow from Investing Activities
18.00
8,689.00
-283.00
-216.00
381.00
-7,396.00
Cash Flow from Financing Activities
176.00
-7,172.00
294.00
35.00
-224.00
6,330.00
Net Cash Inflow / Outflow
-792.00
365.00
-28.00
-368.00
70.00
-533.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
-4.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Cytori Cell Research Institute, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-2152.797
501.134
-2,653.00
-529.59%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-267.691
-1316.313
1,049.00
79.66%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-987.038
-1136.82
149.00
13.18%
Cash Flow from Investing Activities
18.125
-842.871
860.00
102.15%
Cash Flow from Financing Activities
176.426
1718.977
-1,542.00
-89.74%
Net Cash Inflow / Outflow
-792.487
-260.714
-532.00
-203.97%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 14.34% vs -2,815.71% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
-987.04
-1,152.23
14.34%






